BioMotiv, Rutgers launch TamRx

BioMotiv, Rutgers launch TamRx

Source: 
BioCentury
snippet: 

Cancer immunotherapy company TamRx LLC (Cleveland, Ohio) launched Thursday from pharmaceutical accelerator BioMotiv LLC (Cleveland, Ohio), shooting to reach the clinic with its pan-TAM inhibitors in 2021.